课题基金 / 基金详情

Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay

Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay
使用微核测定法检测碘 131 治疗甲状腺癌后的放射毒性
批准号:
08671009
负责人:
WATANABE Naoto
金额:
$1.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

WATANABE Naoto的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
radiation damage to lymphocytes after I- 131 therapy using the cytokines is-blocked micronucleus as s a y . The chromosomal damage to lymphocytes induced by I-131 in vivo should result in augmentation of the cells with micronuclei. Methods ; We studied 25 patients with differentiated thyroid carcinoma, who were treated with 3.7 GBq of I- 131. Isolated lymphocytes collected from patients 1 week after therapy were harvested and treated according to the cytokines is-blocked method of Fenech and Morley. Micronuclens number of micronuclei per 500b inucleated cells was scored by visual inspction. As controls, lymphocytes from the same patients before therapy were also studied. In an in vitro study, lymphocytes from three patients at least 3 months after therapy were exposed doses varying from 0.25 to 1 Gy and stud led with the same method. Results : The mean number (mean*SD) of micronuclei after treatment was significantly increased (p<0.05) as comparted to control subjects (15.7* 2.7 vs. 5.4 * 1.4). Since there was an interval ranging from 6 to 20 months (mean 11.8 months) between the present and the last radio iodine therapy, no significant effect on the frequency of micronucleus with cumulative radiation exposure of I- 131 to lymphocytes was detected. Internal radiation absorbed doses estimated for 25 patients were 0.33 0.09 Gy ln this external irradiation study. C o n c I u s i o n s : The relatively low frequency of lymphocyte micronuclei induced by iodine-13 1 in vivo and lack of significant effect on the frequency of lymphocyte micronuclei with cumulative iodine-131 s u p p o r t e d the contention t h a t short-term non-stochastic damage of this therapy with 3 .7 G B q of 1-131 in thyroid cancer patientsis minimal and reversible .
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Watanabe N., Yokoyama K., Kinuya S., et al.: "Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay." J Nucl Med. 39. 436-440 (1998)
Watanabe N.、Yokoyama K.、Kinuya S. 等人:“使用微核测定法检测碘 131 治疗甲状腺癌后的放射毒性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Naoto Watanabe et al: "Radiotoxicity After Iochine-131 Therapy for Thyroid Cancer Using the Micronuclens Assay" Journal of Nuclear Medicine. 39. 436-440 (1998)
Naoto Watanabe 等人:“使用微核试验进行甲状腺癌 Iochine-131 治疗后的放射毒性”核医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Naoto Watanabe et al: "Radiotoxicity after Iodine-131 Therapy for Thyroid Cancer Using the Micronucleous Assay" Journal of Nuclear Medicine. 39. 436-440 (1998)
Naoto Watanabe 等人:“使用微核测定法对甲状腺癌进行碘 131 治疗后的放射毒性”核医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Watanabe N,et al: "Evaluation of radiotoxicity after iodine-131therapy for thyroid Cancer using the micronucleus assay" Journal of Nuclear Medicine. 37(Suppl). 101-102 (1996)
Watanabe N 等人:“使用微核测定法评估甲状腺癌碘 131 治疗后的放射毒性”核医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Evaluation of radiotoxicity after Ra-223 therapy using gamma-H2AX foci formation in lymphocytes.
  • 批准号:
    16K10366
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2016
  • 负责人:
    WATANABE Naoto
  • 依托单位:
Evaluation of radiotoxicity after iodine-131 therapy using DNA damage in lymphocytes
  • 批准号:
    24591794
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    WATANABE Naoto
  • 依托单位:
Empirical Analysis of the Motivational Effects of Strategic Communication Using the Balanced Scorecard in Japanese Hospitals
  • 批准号:
    21730384
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.5万
  • 财政年份:
    2009
  • 负责人:
    WATANABE Naoto
  • 依托单位:
Evaluation of radiotoxicity to lymphocytes after Yttrium-90-labelled monoclonal anti-CD20 antibody therapy
  • 批准号:
    20591435
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2008
  • 负责人:
    WATANABE Naoto
  • 依托单位: